FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3045226759> ?p ?o ?g. }

• W3045226759 endingPage "10139" @default.
• W3045226759 startingPage "10128" @default.
• W3045226759 abstract "Abstract Apatinib (YN968D1) is a small‐molecule tyrosine kinase inhibitor（TKI）which can inhibit the activity of vascular endothelial growth factor receptor‐2 (VEGFR‐2). It has been reported that apatinib has anti‐tumour effect of inhibiting proliferation and inducing apoptosis of a variety of solid tumour cells, whereas its effect on vascular smooth muscle cells (VSMC) remains unclear. This study investigated the effect of apatinib on phenotypic switching of arterial smooth muscle cells in vascular remodelling. Compared to the vehicle groups, mice that were performed carotid artery ligation injury and treated with apatinib produced a reduction in abnormal neointimal area. For in vitro experiment, apatinib administration inhibited VSMC proliferation, migration and reversed VSMC dedifferentiation with the stimulation of platelet‐derived growth factor type BB (PDGF‐BB).In terms of mechanism, with the preincubation of apatinib, the activations of PDGF receptor‐β (PDGFR‐β) and phosphoinositide‐specific phospholipase C‐γ1 (PLC‐γ1) induced by PDGF‐BB were inhibited in VSMCs. With the preincubation of apatinib, the phosphorylation of PDGFR‐β, extracellular signal‐related kinases (ERK1/2) and Jun amino‐terminal kinases (JNK) induced by PDGF‐BB were also inhibited in rat vascular smooth muscle cell line A7r5. Herein, we found that apatinib attenuates phenotypic switching of arterial smooth muscle cells induced by PDGF‐BB in vitro and vascular remodelling in vivo. Therefore, apatinib is a potential candidate to treat vascular proliferative diseases." @default.
• W3045226759 created "2020-07-29" @default.
• W3045226759 creator A5034686784 @default.
• W3045226759 creator A5035094245 @default.
• W3045226759 creator A5047277837 @default.
• W3045226759 creator A5048521154 @default.
• W3045226759 creator A5069565988 @default.
• W3045226759 creator A5089974219 @default.
• W3045226759 date "2020-07-22" @default.
• W3045226759 modified "2023-10-14" @default.
• W3045226759 title "Apatinib attenuates phenotypic switching of arterial smooth muscle cells in vascular remodelling by targeting the PDGF Receptor‐β" @default.
• W3045226759 cites W1547736903 @default.
• W3045226759 cites W1966018982 @default.
• W3045226759 cites W1983390546 @default.
• W3045226759 cites W1994135302 @default.
• W3045226759 cites W2006265381 @default.
• W3045226759 cites W2015219342 @default.
• W3045226759 cites W2015338496 @default.
• W3045226759 cites W2023653988 @default.
• W3045226759 cites W2044601662 @default.
• W3045226759 cites W2049010780 @default.
• W3045226759 cites W2067235900 @default.
• W3045226759 cites W2074644169 @default.
• W3045226759 cites W2121822802 @default.
• W3045226759 cites W2124172600 @default.
• W3045226759 cites W2145092426 @default.
• W3045226759 cites W2293170306 @default.
• W3045226759 cites W2580071212 @default.
• W3045226759 cites W2747989445 @default.
• W3045226759 cites W2789473108 @default.
• W3045226759 cites W2796711492 @default.
• W3045226759 cites W2895794200 @default.
• W3045226759 cites W2900088351 @default.
• W3045226759 cites W2922360615 @default.
• W3045226759 cites W4250908540 @default.
• W3045226759 cites W928816491 @default.
• W3045226759 doi "https://doi.org/10.1111/jcmm.15623" @default.
• W3045226759 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7520274" @default.
• W3045226759 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32697395" @default.
• W3045226759 hasPublicationYear "2020" @default.
• W3045226759 type Work @default.
• W3045226759 sameAs 3045226759 @default.
• W3045226759 citedByCount "7" @default.
• W3045226759 countsByYear W30452267592021 @default.
• W3045226759 countsByYear W30452267592022 @default.
• W3045226759 countsByYear W30452267592023 @default.
• W3045226759 crossrefType "journal-article" @default.
• W3045226759 hasAuthorship W3045226759A5034686784 @default.
• W3045226759 hasAuthorship W3045226759A5035094245 @default.
• W3045226759 hasAuthorship W3045226759A5047277837 @default.
• W3045226759 hasAuthorship W3045226759A5048521154 @default.
• W3045226759 hasAuthorship W3045226759A5069565988 @default.
• W3045226759 hasAuthorship W3045226759A5089974219 @default.
• W3045226759 hasBestOaLocation W30452267591 @default.
• W3045226759 hasConcept C101544691 @default.
• W3045226759 hasConcept C11960822 @default.
• W3045226759 hasConcept C121608353 @default.
• W3045226759 hasConcept C126322002 @default.
• W3045226759 hasConcept C134018914 @default.
• W3045226759 hasConcept C146285616 @default.
• W3045226759 hasConcept C14858245 @default.
• W3045226759 hasConcept C167734588 @default.
• W3045226759 hasConcept C170493617 @default.
• W3045226759 hasConcept C180361614 @default.
• W3045226759 hasConcept C26375932 @default.
• W3045226759 hasConcept C2775960820 @default.
• W3045226759 hasConcept C2777025900 @default.
• W3045226759 hasConcept C2777553839 @default.
• W3045226759 hasConcept C2779395532 @default.
• W3045226759 hasConcept C2780668389 @default.
• W3045226759 hasConcept C2781294074 @default.
• W3045226759 hasConcept C2992686903 @default.
• W3045226759 hasConcept C42362537 @default.
• W3045226759 hasConcept C502942594 @default.
• W3045226759 hasConcept C62478195 @default.
• W3045226759 hasConcept C71924100 @default.
• W3045226759 hasConcept C86803240 @default.
• W3045226759 hasConcept C95444343 @default.
• W3045226759 hasConceptScore W3045226759C101544691 @default.
• W3045226759 hasConceptScore W3045226759C11960822 @default.
• W3045226759 hasConceptScore W3045226759C121608353 @default.
• W3045226759 hasConceptScore W3045226759C126322002 @default.
• W3045226759 hasConceptScore W3045226759C134018914 @default.
• W3045226759 hasConceptScore W3045226759C146285616 @default.
• W3045226759 hasConceptScore W3045226759C14858245 @default.
• W3045226759 hasConceptScore W3045226759C167734588 @default.
• W3045226759 hasConceptScore W3045226759C170493617 @default.
• W3045226759 hasConceptScore W3045226759C180361614 @default.
• W3045226759 hasConceptScore W3045226759C26375932 @default.
• W3045226759 hasConceptScore W3045226759C2775960820 @default.
• W3045226759 hasConceptScore W3045226759C2777025900 @default.
• W3045226759 hasConceptScore W3045226759C2777553839 @default.
• W3045226759 hasConceptScore W3045226759C2779395532 @default.
• W3045226759 hasConceptScore W3045226759C2780668389 @default.
• W3045226759 hasConceptScore W3045226759C2781294074 @default.
• W3045226759 hasConceptScore W3045226759C2992686903 @default.
• W3045226759 hasConceptScore W3045226759C42362537 @default.
• W3045226759 hasConceptScore W3045226759C502942594 @default.

• next